Off the wire
• Philippine court of appeals affirms conviction of U.S. soldier for killing local transgender  • U.S. stocks open higher after jobs report  • China's air quality improves in March  • Tibet recognizes more traditional medicine practitioners  • Results of Chinese National Swimming Championships  • Senior CPC leader calls for better publicity work for national congress  • Sudan reiterates moral commitment to people of South Sudan  • 1st LD Writethru: First China-bound direct freight train leaves London  • 1st Ld-Writethru-China Focus: President Xi meets Norwegian PM to enhance mutual trust  • IMF, World Bank, WTO urge nations to advance open trade  
You are here: 　 Home

China to build umbilical cord blood stem cell resource sharing platform

Xinhua, April 10, 2017 Adjust font size:

A national health institute and a cell and gene engineering firm inked an agreement Monday on a new sharing platform to support umbilical cord stem cell research.

The umbilical cord blood bank in Tianjin Municipality will upload the information. The blood bank is affiliated to VCANBIO Cell&Gene Engineering, which has the largest cell resource storage network in the country with more than 300,000 copies. It is currently the only company of its kind listed on a Chinese bourse.

"The national umbilical cord blood stem cell resource sharing service platform, once it has enough data to share, will be an open resource," said Wang Dehai, from the institute of science and technology of the National Health and Family Planning Commission.

Umbilical cord blood stem cell transplants are used to treat major and refractory diseases such as severe thalassemia, acute lymphoblastic leukemia, acute myeloid leukemia.

China has umbilical cord blood stem cell banks in Beijing, Tianjin, Shanghai, Guangdong and other places.

The one in Tianjin has provided more than 1,000 transplant donors for clinical and scientific research. Endi